brands of glp 1 drugs GLP-1 Agonists: A Comprehensive Overview GLP-1 supplements are everywhere—but do

methodology, A.F

Figure 1 shows the most relevant aspects of the benefits/risks profile of GLP-1 RAs

As additional data accrue, future analyses should examine persistence, switching over time, and clinical outcomes associated with oral semaglutide use

Goal: Type 2 diabetes management (A1C reduction) If you prefer once-weekly injections: Semaglutide (Ozempic), tirzepatide (Mounjaro), dulaglutide (Trulicity), or efpeglenatide (Eperzan) If you prefer daily injections: Liraglutide (Victoza) or lixisenatide (Adlyxin) If you prefer oral medication: Semaglutide (Rybelsus) If cost is the primary concern: Compounded semaglutide or compounded tirzepatide (if eligible under shortage provisions) Goal: Weight loss (obesity or overweight with comorbidities) If you want maximum weight loss: Retatrutide (Retara, triple agonist, 24% mean loss) or tirzepatide (Zepbound, dual agonist, 20% to 22% mean loss) If you want proven long-term safety data: Semaglutide (Wegovy, 15% to 17% mean loss, 5+ years post-approval data) If you prefer oral medication: Orforglipron (Orfoglip, 15% mean loss, oral once daily) If cost is the primary concern: Compounded semaglutide or compounded tirzepatide Goal: Both diabetes and weight loss If you have significant obesity (BMI over 35): Tirzepatide (Mounjaro for diabetes indication, Zepbound for obesity indication

Practical Reasons: Want Telehealth Convenience The Problem: In-person doctor visits required for Mounjaro prescription No local provider prescribes weight loss medications Dont have time for multiple appointments Prefer virtual healthcare The Solution: Telehealth platforms offering compounded tirzepatide provide complete service online, from consultation through delivery